期刊文献+

大容量全肺灌洗术治疗合并严重低氧血症肺泡蛋白沉积症1例并文献复习 被引量:2

Large-capacity whole-lung lavage in 1 patient with pulmonary alveolar proteinosis and severe hypoxemia and literature review
下载PDF
导出
摘要 对中南大学湘雅医院呼吸内科首例行大容量全肺灌洗术成功治疗合并严重低氧血症的肺泡蛋白沉积症患者的临床资料进行分析,并复习相关文献。男性患者,35岁,咳嗽、气促2年余入院。入院检查发现患者严重低氧血症,双肺弥漫性间质病变,经肺活检诊断肺泡蛋白沉积症,在静脉全麻下经双腔气管插管,大容量全肺灌洗术。并联合使用粒-巨噬细胞集落刺激因子(granulocyte-macrophage colonystim ulating factor,GM-CSF)皮下注射。术后患者自觉症状明显改善,胸部CT及动脉血气均有明显改善。 To improve the diagnosis and treatment of pulmonary alveolar proteinosis, clinical data for the first successfully treated case of pulmonary alveolar proteinosis with severe hypoxemia by large-capacity wholelung lavage in our hospital were analyzed, and relevant literatures were reviewed. A 35-year-old Han male initially presented two years ago with increasing cough and dyspnea was admitted to our hospital Admission examination revealed severe hypoxemia, interstitial lung disease, and heavy protein deposition in the alveoli by lung biopsy The patient received large-capacity whole-lung lavage in the operation room under general anesthesia and treatment of granulocyte-macrophage colony stimulating factor (GM-CSF). The patient's symptoms of dyspnea were alleviated markedly; and radiological findings improved and A-aDO2 decreased.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2012年第10期1077-1080,共4页 Journal of Central South University :Medical Science
关键词 肺泡蛋白沉积症 全肺灌洗 低氧血症 GM-CSF pulmonary alveolar proteinosis whole-lung lavage hypoxemia GM-CSF
  • 相关文献

参考文献13

  • 1Shah PL, HanseU D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis[J]. Thorax, 2000, SS(1): 67-77.
  • 2Byun MK, Kim DS, Kim YW, et al. Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population[J]. J Korean Med Sci, 2010, 25(3): 393-398.
  • 3Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis[J]. N EnglJ Med, 2003, 349(26): 2527-2539.
  • 4Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan[J]. AmJ Respir Crit Care Med, 2008, 177(7): 7.52-762.
  • 5Huizar I, Kavuru MS. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management[J]. Curr Opin Pulm Med, 2009, 15(5): 491-498.
  • 6Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis [J]. Eur Respir J, 2004, 23(4): 526-531.
  • 7Dranoff G, Mulligan RC. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies[J]. Stem Cells, 1994, 12(1): 173-182.
  • 8Shibata Y, Berclaz PY, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1 [J]. Immunity, 2001, 15(4): 557-567.
  • 9Sergeeva A, Ono Y, RJos R, et al. High titer autoantibodies to GM- CSF in patients with AML, CML and MDS are associated with active disease [J]. Leukemia, 2008, 22(4): 783-790.
  • 10Kavuru MS, Sullivan EJ, Piccin R, et al. Exogenous granulocyte- macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis [J]. Am J Respir Crit Care Med, 2000, 161(4): 1143-1148.

二级参考文献18

  • 1Seymour JF,Presneill JJ. Pulmonary alveolar proteinosis:progress in the first 44 years. Am J Respir Crit Care Med,2002,166:215-235.
  • 2Trapnell BC,Whitsett JA,Nakata K. Pulmonary alveolar proteinosis. N Engl J Med,2003,349:2527-2539.
  • 3Kitamura T,Uchida K,Tanaka N,et al. Serological diagnosis of idopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,162(2 Pt 1):658-662.
  • 4Bonfield TL,Russell D,Burgess S,et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol,2002,27:481-486.
  • 5Carraway MS,Ghio AJ,Carter JD,et al. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161(4 Pt 1):1294-1299.
  • 6Bonfield TL,Russell D,Burgess S,et al. Hematopoietic colony stimulating factor in pulmonary alveolar proteinosis(PAP). 98th International Conference of American Thoracic Society,2002 [A35] [poster:C68]. Available from:URL:http://www.thoracic.org/ic/ic2002
  • 7Kavuru MS,Sullivan EJ,Piccin R,et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161(4 Pt 1):1143-1148.
  • 8Seymour JF,Presneill JJ,Schoch OD,et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med,2001,163:524-531.
  • 9Tanaka N,Watanabe J,Kitamura T,et al. Lungs of patients with idopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett,1999,442:246-250.
  • 10Uchida K,Nakata K,Trapnell BC,et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood,2004,103:1089-1098.

共引文献33

同被引文献3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部